LISA SPRINGER: Open Payments
NPI 1760606370 · WARRENTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,764 in 93 payments from 25 companies in 2025. Trend: 2023 $1,878 · 2024 $1,704 · 2025 $1,764
Food & beverage: $1,764
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $227 |
| Amgen Inc. | 14 | $215 |
| AstraZeneca Pharmaceuticals LP | 11 | $215 |
| Novo Nordisk Inc | 8 | $164 |
| PFIZER INC. | 6 | $152 |
| Abbott Laboratories | 5 | $89 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Lilly USA, LLC | 2 | $58 |
| Exact Sciences Corporation | 2 | $57 |
| Vifor Pharma, Inc. | 3 | $50 |
Products named: OTEZLA, VRAYLAR, AIRSUPRA, Ozempic, PREVNAR 20, FREESTYLE LIBRE 3, BREZTRI, TRELEGY ELLIPTA.
Industry payments across VA — which companies pay providers there.
